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Abstract
Background: Verbal autopsy can be a useful tool for generating cause of death data in data-sparse regions around
the world. The Symptom Pattern (SP) Method is one promising approach to analyzing verbal autopsy data, but it
has not been tested rigorously with gold standard diagnostic criteria. We propose a simplified version of SP and
evaluate its performance using verbal autopsy data with accompanying true cause of death.
Methods: We investigated specific parameters in SP’s Bayesian framework that allow for its optimal performance in
both assigning individual cause of death and in determining cause-specific mortality fractions. We evaluated these
outcomes of the method separately for adult, child, and neonatal verbal autopsies in 500 different population
constructs of verbal autopsy data to analyze its ability in various settings.
Results: We determined that a modified, simpler version of Symptom Pattern (termed Simplified Symptom Pattern,
or SSP) performs better than the previously-developed approach. Across 500 samples of verbal autopsy testing
data, SSP achieves a median cause-specific mortality fraction accuracy of 0.710 for adults, 0.739 for children, and
0.751 for neonates. In individual cause of death assignment in the same testing environment, SSP achieves 45.8%
chance-corrected concordance for adults, 51.5% for children, and 32.5% for neonates.
Conclusions: The Simplified Symptom Pattern Method for verbal autopsy can yield reliable and reasonably
accurate results for both individual cause of death assignment and for determining cause-specific mortality
fractions. The method demonstrates that verbal autopsies coupled with SSP can be a useful tool for analyzing
mortality patterns and determining individual cause of death from verbal autopsy data.
Keywords: Verbal autopsy, Symptom Pattern, validation, gold standard
Background
Methods for analyzing verbal autopsies (VAs) seek to
predict causes of death and/or cause-specific mortality
fractions (CSMFs) based solely on a decedent’ss i g n s
and symptoms leading up to death. The signs and symp-
toms for a given death are recorded in an interview with
a member of the decedent’s family. The family member’s
responses can then be analyzed to deduce the true cause
of death through either physician-certified verbal
autopsy (PCVA) or computer-coded verbal autopsy
(CCVA). One CCVA approach proposed in 2007 by
Murray et al. [1] was the Symptom Pattern (SP)
Method. SP is a Bayesian approach that implements sta-
tistical machinery similar to the InterVA program [2],
developed by Byass et al. [3] in 2003. InterVA relies on
expert judgment to determine the probability of a parti-
cular cause of death given a reported symptom, while
SP is a data-driven approach which invokes 1) King-Lu
direct CSMF estimation [4] as the prior probability dis-
tribution, and 2) the actual probability of responses to
combinations of items conditional on true cause in ver-
bal autopsy data, which includes the true cause of death.
The validated verbal autopsy data essentially trains the
model, and the resulting model can then be applied to
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of death is unknown. These unknown deaths are then
assigned a predicted cause of death based on the poster-
ior distribution of the probability of death being due to
each cause. Each cause’s predicted deaths can then be
aggregated to produce estimates of cause-specific mor-
tality fractions in the population of verbal autopsy data
being analyzed.
The SP Method has previously been implemented in
the R programming language due to its flexibility and
compatibility with the King-Lu algorithm. For users
unfamiliar with computer programming, this interface
can pose difficulties. Furthermore, the computational
complexity and depth used in both the King-Lu and SP
algorithms can make it difficult for operators to unpack
the quantitative rationale of a cause assignment for a
particular death. Despite these obstacles, SP has demon-
strated success in both assigning individual cause of
death and determining cause-specific mortality fractions.
In a study of verbal autopsy data from China, SP per-
formed better than PCVA [1].
During the last four years of verbal autopsy research, a
number of conceptual, methodological, and empirical
innovations have occurred. First, it is increasingly clear
that methods such as King-Lu and SP can identify very
complex patterns in data. It is essential in evaluating
these methods to strictly separate training and test data
even when complex resampling is undertaken. Prevent-
ing the contamination of test data with train data per-
mits the evaluation of how well a given method will
work in practice. Second, Murray et al. [5] have identi-
fied that many metrics of performance such as specifi-
city or relative and absolute error in CSMFs are
sensitive to the CSMF composition of the test data set.
Robust assessment of performance must be undertaken
across a range of test datasets with widely varying
CSMF compositions. Further, metrics of individual con-
cordance need to be corrected for chance to adequately
capture how well a method does over and above ran-
dom or equal assignment across causes. Third, the
Population Health Metrics Research Consortium
(PHMRC) multisite study [6] provides the first large-
scale data set where rigorous clinical diagnostic criteria
have been used to assign cause of death in the validation
dataset. The availability of improved gold standards pro-
vides an opportunity to assess more accurately how well
methods perform.
Several developments suggest that SP as originally
proposed can be simplified with enhanced performance.
Flaxman et al. [7] have studied when the King-Lu
method of direct CSMF estimation provides accurate
CSMFs. They report that when the cause list is larger
than seven to 10 causes, the results of King-Lu can be
quite inaccurate. Using these CSMFs as a prior in SP
may actually make performance of the method worse.
Lessons learned in studies of pairwise analysis [8] have
also suggested that two strategies may improve perfor-
mance: 1) developing models for each cause compared
to all other causes, one at a time, may be better than a
model for all causes at once, and 2) using a smaller,
more informative set of items for each cause may
improve performance. Building on these insights, we
propose a simplified version of the Symptom Pattern
Method and assess its performance using the PHMRC
gold standard validation train and test datasets.
Methods
Options for modifying the Symptom Pattern Method
The basis for the SP Method is Bayes’ theorem applied
to cause of death analysis. Formally:
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Where Si is the response pattern on a set of k items in
the VA (not simply one item), and where P(Di = j|Si)i s
the probability of individual i dying from cause j,c o n d i -
tional on the observed vector of symptom responses, Si.
Examination of Bayes’ theorem highlights four options
for SP modification.
First, we can develop a model for one cause at a time
that produces a posterior probability of a death being
from that cause or not from that cause. In the notation
provided, Di =jor not j. Alternatively we can develop a
model as originally proposed for all causes at the same
time where Di =jfor j from 1 to the last cause.
Second, the prior can be baseda so r i g i n a l l yp r o p o s e d
on the application of the King-Lu approach to direct
CSMF estimation, or it can be based on a uniform prior
where all causes are considered to be equally likely. In
the case of single cause models, a uniform prior would
say the probability of a death being from cause j and all
other causes other than j would be equal.
Third, in the original SP the responses on all items
were used simultaneously. Alternatively, we have
observed in other verbal autopsy research that it is pos-
s i b l et oi m p r o v es i g n a l si nt h ed a t ab yo n l yi n c l u d i n g
the most informative items for a given cause in that
cause-specific model. Specifically, we can use the top
items for a cause ordered by their tariff [9]. Tariff is
most easily viewed as a robust Z score identifying when
particular signs or symptoms have high information
content for a particular cause. In this analysis, we tested
a range of options and conducted our comparative ana-
lyses using the top 40 items per cause in terms of the
absolute value of the tariff.
Fourth, we can vary the number of items evaluated at
each time to determine a response pattern. The original
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ter size of 10 versus one. The lower cluster size of 10
compared to 16 improves speed and stability of the
results without reducing performance. We have evalu-
ated dropping all interdependencies, because a method
with cluster size one could be implemented much more
efficiently in many computational platforms. Under-
standing the importance of clustering is an important
dimension to SP.
Because using the top 40 symptoms ordered by tariff
is only meaningful for single cause models, in total
these four options yield 12 possible modifications of SP.
In all of these modifications, including the single cause
models, we have assigned the final cause of death using
the highest posterior value by cause. When assigning
more than one cause of death, we have assigned the
highest posterior first, the second highest next, etc.
Validation using the PHMRC gold standard train-test
datasets
As described elsewhere in more detail [6], the PHMRC
gold standard verbal autopsy validation study provides a
unique and large multisite dataset to assess the perfor-
mance of new or existing verbal autopsy methods. The
PHMRC study collected VAs on deaths that met defined
clinical diagnostic criteria for cause of death. For exam-
ple, a death from an acute myocardial infarction
required evidence as obtained by one or more of the fol-
lowing: a cardiac perfusion scan; ECG changes; docu-
m e n t e dh i s t o r yo fc o r o n a r ya r t e r yb y p a s ss u r g e r y ,
percutaneous transluminal coronary angioplasty, or
stenting; coronary angiography; and/or enzyme changes
in the context of myocardial ischemia. As part of the
PHMRC study, all variables including free-text responses
regarding health care experiences (HCE) have been con-
verted into a series of dichotomous items, which can be
analyzed by SP. Table 1 provides the number of items
in the adult, child, and neonatal modules. The PHMRC
has developed a fixed set of 500 train and test splits of
the data to allow for direct performance comparison
between methods. We have analyzed all 500 of these
splits for the final validation results presented in this
paper. We have used the first 100 and second 100 splits
to select the best variant of SP for simplifying the
approach. For each split, we use the training data for SP
to establish the P(Sik|Di = j) and then apply these pat-
terns to the test dataset. In no case are there deaths in
the training data that are replicated in the test data.
Further, the cause composition of the test dataset is
based on a random draw from an uninformative Dirich-
let distribution so that the cause composition of the
training data and test data are always different.
Simplifying Symptom Pattern
To select the best-performing variant, we conducted
three types of analyses. We assess the performance of
the different variants of SP at assigning individual causes
of death using median chance-corrected concordance by
cause across the first 100 test datasets and the median
average chance-corrected concordance across causes in
the 100 test datasets following the recommendations of
Murray et al. [5]. For assessing the performance of SP in
estimating CSMFs, we report median CSMF accuracy
[5] as well as concordance correlation coefficients by
cause as a summary of the relationship between esti-
mated CSMFs for a cause and the true CSMF in a parti-
cular test dataset. To explore the comparative
performance of all 12 SP variants, we have undertaken
this assessment for adults, children, and neonates using
household recall of HCE. On the basis of these results,
we have selected a simplified approach, which we have
implemented for children and neonates. To insure that
this analysis did not yield results that were biased by
analyzing the first 100 train-test splits, we repeated this
analysis for the second 100 splits. We also confirmed
that the results were robust to the selection of splits by
analyzing five sets of randomly-drawn test-train splits of
size 50. In the text, we present results for the analysis of
the first 100 splits, but our findings are robust across
the other tests. On the basis of these results, we select
one variant as the Simplified Symptom Pattern (SSP)
Method.
Validation of Simplified Symptom Pattern Method
Using the full 500 train-test splits in the PHMRC data-
set, we assess the performance of the SSP Method. We
benchmark variants of SP with each other and against
PCVA in the same dataset using the results reported by
Lozano et al. [10].
Murray et al. [1] analyzed data for China two ways:
including all items and excluding items that reflected
the decedent’s contact with health services. The pur-
pose of excluding the latter structured and free-text
items was to assess how VA would perform in poor
rural populations without access to care. They found,
for example, that a considerable component of PCVA
performance was related to the household recall of
hospital experience or availability of a death certificate
Table 1 Numbers of items in adult, child, and neonate
modules
Dichotomous Continuous Categorical Free text Total
Adult 130 25 32 7* 194
Child 55 13 29 7* 104
Neonate 76 21 33 7* 137
*Free text responses were dichotomized as individual words and expanded
into 106, 90, and 39 items for adults, children, and neonates, respectively.
Total does not include these expanded items.
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the performance of our SSP Method in adults, chil-
dren, and neonates excluding the household recall of
HCE.
Results
Analysis of the performance of SP alternatives
Table 2 summarizes the median chance-corrected con-
cordance and CSMF accuracy for all 12 SP variants on
each age module including household recall of HCE.
The table identifies each variant in terms of four attri-
butes: symptom cluster size (10 versus one), cause-
models (models for each single cause compared to
noncause versus one model for multiple causes), the
number of symptoms used in the likelihood step of
Bayes’ theorem (all versus the top 40), and the prior
CSMF distribution (based on the application of King-
Lu versus a uniform prior). The best results for adults
are for the variant that uses a cluster size of 10, mod-
els for each cause compared to noncause, the top 40
symptoms, and a uniform prior. However, we observed
that other variants produced higher performance in
children and neonates. W ec h o s et ou s et h em o d e l
specifications that produced the most consistent
results across age modules by considering the rank of
each variant for each age group on both chance-cor-
rected concordance and CSMF accuracy. In particular,
we found that using a cluster size of 10, running sin-
gle cause models, using all symptoms, and using a uni-
form prior would produce the best results across
modules. A close second in terms of overall perfor-
mance is the variant using a cluster size of 10, running
single cause models, using the top 40 symptoms based
on tariff, and using a uniform prior. In fact, this var-
iant did best on both metrics for adults but worse for
neonates and children than the variant selected. The
only difference between the two top performing var-
iants is the set of symptoms included. In general,
changes from single cause models to one model for
multiple causes have small decrements in perfor-
mance. Large drops in performance are associated
with shifting from the uniform prior to the King-Lu
prior and shifting from using a symptom cluster size
of 10 compared to one.
Our findings on which variant performs best were
consistent across other tests, including reassessment of
performance for the second 100 test-train splits and
assessment on randomly drawn test-train splits. In all
cases, the shift from uniform priors to King-Lu priors
and from cluster size 10 to cluster size one is associated
with substantial decrements in performance. This sim-
plified variant of SP -Simplified Symptom Pattern - per-
forms substantially better than the original version
published in 2007.
Simplified SP applied to adults, children, and neonates
compared to PCVA
Individual cause assignment
Table 3 shows the comparative performance of SSP ver-
sus PCVA in terms of chance-corrected concordance.
For adults, SSP outperforms PCVA on the same test
datasets both with and without household recall of
health care experience. For children, SSP produces bet-
ter chance-corrected concordance in comparison to
PCVA both when health care information is added and
withheld. For neonates, SSP does better than PCVA
without HCE and slightly worse than PCVA when HCE
information is added, though direct comparison is not
possible since PCVA analysis was limited to six neonatal
causes, while SSP predicted for 11 neonatal causes.
Figures 1, 2, and 3 highlight the hierarchy of cause-
specific chance-corrected concordances in the adult,
child, and neonatal modules, respectively. These figures
also emphasize the extent to which the addition of
health care experience information can inform the pre-
dictions for certain causes. AIDS in the adult module,
for example, achieves much higher chance-corrected
concordance upon addition of HCE. Additional file 1
provides the chance-corrected concordances by cause
with and without HCE for SSP. Remarkably, for 15
adult causes with HCE, chance-corrected concordances
are above 50%. These causes include all the injuries but
also causes such as stroke, AIDS, cirrhosis, cervical can-
cer, esophageal cancer, and breast cancer. Even when
HCE is excluded, chance-corrected concordance is
higher than 50% for 13 causes. The causes with the
worst performance included some cancers such as color-
ectal, stomach, prostate, and leukemia/lymphoma. Resi-
dual categories such as other noncommunicable, other
cardiovascular, and other infectious diseases do particu-
larly poorly. In addition, both renal failure and pneumo-
nia are notable for very low chance-corrected
concordances.
Additional file 1 for children highlights good perfor-
mance for the injuries but also for measles, hemorrhagic
f e v e r ,A I D S ,p n e u m o n i a ,a n dm a l a r i a .A sw i t ha d u l t s ,
poor performance is notable for residual categories such
as other cancers, other infectious diseases, and other
cardiovascular diseases. In neonates (also shown in
Additional file 1) SSP does well for stillbirths, preterm
delivery and sepsis/birth asphyxia, meningitis/sepsis, and
birth asphyxia.
CSMF estimation
Table 4 shows the CSMF accuracy achieved by SSP in
comparison to PCVA for adults, children, and neonates
with and without HCE. In all cases, SSP performs sub-
stantially better and generates more accurate estimated
CSMFs than PCVA on exactly the same validation data-
sets. Neonate results for CSMF accuracy are not
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modules, including use of health care experience information
Adult module:
Cluster Single/Multiple Symptom Prior CSMF accuracy
(95% uncertainty interval [UI])
Chance-corrected concordance
(%) (95% UI)
10 Single Top 40 Uniform 0.726 (0.714, 0.737) 47.8 (47.4, 48.2)
10 Single All Uniform 0.703 (0.687, 0.718) 45.6 (44.9, 46.3)
10 Single Top 40 King-Lu 0.653 (0.640, 0.672) 42.6 (42.1, 43.4)
10 Single All King-Lu 0.311 (0.291, 0.349) 18.4 (17.4, 20.3)
10 Multiple All Uniform 0.714 (0.697, 0.721) 46.1 (45.7, 46.5)
10 Multiple All King-Lu 0.708 (0.696, 0.719) 46.0 (45.6, 46.6)
1 Single Top 40 Uniform 0.668 (0.652, 0.681) 42.7 (42.2, 43.0)
1 Single All Uniform 0.632 (0.620, 0.643) 40.3 (39.8, 40.5)
1 Single Top 40 King-Lu 0.163 (0.147, 0.212) 9.3 (8.3, 11.0)
1 Single All King-Lu 0.043 (0.031, 0.057) 0.4 (0.0, 0.9)
1 Multiple All Uniform 0.651 (0.636, 0.665) 39.2 (38.4, 39.4)
1 Multiple All King-Lu 0.646 (0.630, 0.664) 38.6 (38.1, 39.2)
Child module:
Cluster Single/Multiple Symptom Prior CSMF accuracy (95% UI) Chance-corrected concordance
(%) (95% UI)
10 Single Top 40 Uniform 0.718 (0.699, 0.738) 45.2 (44.4, 46.2)
10 Single All Uniform 0.740 (0.727, 0.757) 50.9 (50.1, 51.8)
10 Single Top 40 King-Lu 0.633 (0.617, 0.666) 40.4 (39.2, 40.9)
10 Single All King-Lu 0.469 (0.453, 0.516) 36.8 (35.4, 38.0)
10 Multiple All Uniform 0.749 (0.736, 0.766) 51.8 (50.7, 52.9)
10 Multiple All King-Lu 0.759 (0.745, 0.771) 52.1 (51.5, 53.0)
1 Single Top 40 Uniform 0.696 (0.676, 0.715) 44.4 (44.0, 45.5)
1 Single All Uniform 0.705 (0.692, 0.727) 46.9 (45.6, 47.5)
1 Single Top 40 King-Lu 0.263 (0.228, 0.280) 16.6 (14.2, 17.7)
1 Single All King-Lu 0.125 (0.104, 0.161) 3.6 (2.3, 4.5)
1 Multiple All Uniform 0.716 (0.701, 0.733) 47.9 (46.5, 48.7)
1 Multiple All King-Lu 0.723 (0.705, 0.741) 47.9 (47.1, 48.6)
Neonate module:
Cluster Single/Multiple Symptom Prior CSMF accuracy (95% UI) Chance-corrected concordance
(%) (95% UI)
10 Single Top 40 Uniform 0.748 (0.730, 0.766) 29.7 (28.7, 30.6)
10 Single All Uniform 0.741 (0.720, 0.787) 31.7 (31.2, 33.0)
10 Single Top 40 King-Lu 0.679 (0.647, 0.704) 27.9 (25.9, 28.5)
10 Single All King-Lu 0.603 (0.553, 0.624) 19.1 (18.0, 21.8)
10 Multiple All Uniform 0.732 (0.712, 0.745) 34.1 (32.8, 35.5)
10 Multiple All King-Lu 0.736 (0.711, 0.752) 33.6 (32.9, 35.5)
1 Single Top 40 Uniform 0.663 (0.634, 0.691) 28.8 (27.4, 29.6)
1 Single All Uniform 0.604 (0.571, 0.639) 26.4 (25.2, 27.6)
1 Single Top 40 King-Lu 0.425 (0.391, 0.462) 10.0 (9.2, 11.6)
1 Single All King-Lu 0.363 (0.325, 0.384) 0.0 (0.0, 0.5)
1 Multiple All Uniform 0.564 (0.550, 0.580) 29.5 (27.7, 30.4)
1 Multiple All King-Lu 0.565 (0.541, 0.591) 29.4 (27.8, 30.8)
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results are compiled at a six-cause level, whereas SSP is
capable of producing estimates for 11 different causes.
The difference in adults and children can be as large as
0.077 for children without HCE. This represents a sub-
stantial increment in performance at the population
level relative to PCVA.
To explore the variation by cause in SSP’s mortality
fraction estimation, we modeled the estimated CSMF as
af u n c t i o no ft r u eC S M F .A d d i t i o n a lf i l e2s h o w st h i s
relationship based on the true and estimated results
from 500 different test splits in the form
Estimated CSMF = True CSMF × slope + intercept.
This regression allows us to observe the predicted size
of any cause’s mortality fraction even if no true deaths
from that cause exist in the dataset and then to deter-
mine whether SSP will tend to overestimate or underesti-
mate if the true mortality fraction is greater than zero.
Extracting the root mean square error (RMSE) allows for
assessment of the range of estimated CSMFs for a given
true CSMF, therefore indicating whether any over- or
underestimation will be systematic and predictable. This
analysis is a useful way to predict how SSP could perform
in the field, particularly considering the different settings
and project aims that may be focused on different disease
burdens. Based on the results from this regression, we
chose six causes that highlight characteristics of SSP’s
predictions. Figures 4, 5, 6, 7, 8 and 9 show a comparison
of estimated CSMFs and true CSMFs for these six causes:
breast cancer (Figure 4), road traffic (Figure 5), epilepsy
(Figure 6), cervical cancer (Figure 7), acute myocardial
infarction (Figure 8), and chronic obstructive pulmonary
disease (COPD) (Figure 9).
Breast cancer, shown in Figure 4, exemplifies a cause
for which SSP produces accurate CSMF estimates
regardless of the true CSMF size. It has a tendency to
slightly overestimate the CSMF when the true CSMF is
very small. Indeed, results from the regression show
that SSP will predict a CSMF of 1.4% even if there are
no actual deaths from breast cancer. The slope of the
regression in addition to the scatter show, though, that
beyond very small CSMFs for breast cancer, SSP will
typically produce predicted CSMFs that are very close
to the truth. Road traffic in Figure 5 shows a very
similar relationship. Both breast cancer and road traffic
are causes that also obtain a high chance-corrected
concordance, suggesting a strong relationship between
success at individual-level assignment and population-
level estimates. Figure 6 shows how for epilepsy, SSP
will overestimate at lower true CSMFs, but as the true
fraction increases, SSP begins to underestimate. The
regression results confirm this observation. The inter-
cept of the regression for epilepsy is 0.017, indicating
an estimated CSMF of 1.7% will occur even if no true
epilepsy deaths exist. The slope of 0.636 and the
accompanying scatter both suggest that beyond a
CSMF of approximately 4%, SSP will begin to systema-
tically underestimate the mortality fraction from epi-
lepsy. Cervical cancer, shown in Figure 7, highlights a
case where SSP more dramatically overestimates the
CSMF when the true CSMF is less than approximately
9%. Beyond 9%, however, the estimations tend to be
closer to truth. The RMSE for the cervical cancer
regression is 0.013, twice as large as the RMSE for
breast cancer, indicating a noisier range of estimates
for any given true CSMF. Acute myocardial infarction
in Figure 8 is another cause for which SSP systemati-
cally underestimates beyond a 5% true cause fraction,
and has a RMSE of 0.008. A very similar relationship
is shown for COPD in Figure 9.
The RMSE in the adult results with HCE ranges
from 0.003 to 0.015. In the child with HCE results, the
RMSE is typically higher, ranging from 0.006 to 0.027,
highlighting the noisier CSMF estimations that result
from SSP’s use with child VAs. For example, Figure 10
shows the true and estimated CSMFs for hemorrhagic
fever in children, which evidently produces a range of
estimates for any given true CSMF. The neonate
CSMF estimation is also typically less precise than the
adult results, with a RMSE ranging from 0.012 to
0.056. The true and estimated CSMFs for stillbirths are
shown in Figure 11 and demonstrate a cause which is
essentially always subject to overestimation by SSP.
Overall, the analysis of the true versus estimated rela-
tionships suggests that while systematic underestima-
tion or overestimation beyond a certain threshold
CSMF may be an intrinsic characteristic of SSP’sp r e -
dictions, in many cases the trend is still predictable
and precise.
Table 3 Median chance-corrected concordance (%) for
SSP and PCVA, by age group with and without HCE
SSP PCVA
Median 95% UI Median 95% UI
Adult No HCE 38.0 (37.8, 38.1) 29.7 (29.4, 29.8)
HCE 45.8 (45.7, 45.9) 44.6 (44.3, 44.8)
Child No HCE 46.8 (46.5, 47.3) 36.3 (35.9, 36.6)
HCE 51.5 (51.1, 51.9) 47.8 (47.1, 48.3)
Neonate No HCE 30.4 (30.0, 30.7) 27.6 (27.2, 28.0)
HCE 32.5 (32.0, 33.0) 33.3 (32.8, 33.7)
The median chance-corrected concordance is computed as the median across
500 splits of the mean chance-corrected concordance across causes. These
results show how SSP outperforms physicians in individual cause assignment
in every situation where head-to-head comparison is possible, except for the
neonatal module with the HCE information added. In the neonatal module,
SSP cannot be directly compared to PCVA since PCVA analysis could only be
conducted for six neonate causes, while SSP can predict for 11 causes.
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These results suggest that Simplified Symptom Pattern
performs better than the original version proposed by
Murray et al. in 2007. In fact, by dropping the use of
the King-Lu direct CSMFs as the prior in SSP,
performance has improved. This is consistent with the
finding of Flaxman et al. [7] that King-Lu has poor
accuracy when there are more than seven to 10 causes
in the cause list. SSP performance is also enhanced by
developing models for each cause, one at a time, that
Figure 1 Median chance-corrected concordance (%) across 500 Dirichlet splits, by adult cause with and without HCE.
Murray et al. Population Health Metrics 2011, 9:30
http://www.pophealthmetrics.com/content/9/1/30
Page 7 of 14Figure 2 Median chance-corrected concordance (%) across 500 Dirichlet splits, by child cause with and without HCE.
Figure 3 Median chance-corrected concordance (%) across 500 Dirichlet splits, by neonate cause with and without HCE.
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to all other causes and then picking the cause with the
highest posterior probability across the individual cause
models. SSP is further improved by using a cluster size
of 10. These simplifications have led to substantial
improvement in performance.
Simplified Symptom Pattern performs remarkably well
both at individual cause assignment and CSMF estima-
tion. SSP has higher than or equivalent chance-corrected
concordance and CSMF accuracy than PCVA in all
cases, except for the chance-corrected concordance for
neonates with the inclusion of HCE information.
The relative differences in performance, particularly
concerning CSMF accuracy, between the various
implementations of PCVA and SSP presented in this
paper may seem minimal. However, we have observed
that incremental increases in CSMF accuracy in fact
represent substantial improvements. The CSMF accu-
racy ranges from 0.624 to 0.751 across all the cases in
this paper. Two methods would differ in CSMF accuracy
by 10 percentage points if on average over 500 tests, one
cause was misestimated to be 10 CSMF percentage
points higher on average. For the purposes of studying
population health, this difference is quite important.
Lozano et al. [2] report that InterVA, which is also
based on Bayes’ theorem, performs markedly worse than
PCVA or the SSP Method in the same validation data-
set. For individual cause assignment, SSP has a chance-
corrected concordance for adults that is twice as high
with similarly large increments in performance in chil-
dren and neonates. The substantially improved perfor-
mance of SSP in the same validation datasets can be
easily understood by the same dimensions that have
been tested in the simplification of the method. SSP can
be transformed into InterVA by four steps: use a specific
InterVA subset of symptoms, use a cluster size of one,
estimate a model for all causes at once, and use expert
judgment about the probability of a symptom condi-
tional on a cause of death rather than empirical patterns
observed in the training data. All of these choices
Table 4 Median CSMF accuracy for SSP and PCVA, by age
group with and without HCE
SSP PCVA
Median 95% UI Median 95% UI
Adult No HCE 0.671 (0.664, 0.676) 0.624 (0.619, 0.631)
HCE 0.710 (0.704, 0.714) 0.675 (0.669, 0.680)
Child No HCE 0.709 (0.700, 0.717) 0.632 (0.626, 0.642)
HCE 0.739 (0.733, 0.745) 0.682 (0.671, 0.690)
Neonate No HCE 0.748 (0.736, 0.759) 0.695 (0.682, 0.705)
HCE 0.751 (0.737, 0.764) 0.733 (0.719, 0.743)
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Figure 5 True versus estimated mortality fractions for road traffic, adult module with HCE information.
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Figure 6 True versus estimated mortality fractions for epilepsy, adult module with HCE information.
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Figure 7 True versus estimated mortality fractions for cervical cancer, adult module with HCE information.
Figure 8 True versus estimated mortality fractions for acute myocardial infarction, adult module with HCE information.
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Figure 9 True versus estimated mortality fractions for COPD, adult module with HCE information.
Figure 10 True versus estimated mortality fractions for hemorrhagic fever, child module with HCE information.
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Page 12 of 14actually make the performance of a Bayesian approach
worse as demonstrated in this analysis. Lozano et al. [2]
do in fact test SSP and show that one can reduce the
performance of SSP by taking on these InterVA
assumptions.
The main practical limitation of the SSP Method is that
using a symptom cluster size greater than one requires
any analysis of test data to sample from a large training
dataset that captures the complex patterns in symptom
clusters conditional on cause. This means that SSP can-
not be easily delivered to a local analyst for the assess-
m e n to fas i n g l ec a u s eo fd e a t h .T h ec o m p u t a t i o n a l
power required to implement SSP on a single-death basis
is greater than other methods, such as the Tariff Method
or Random Forest Method. For analysis of large groups
of deaths or for research studies, this computational
power may be a reasonable trade-off given the reliable
results produced by the Simplified Symptom Pattern
Method. The SSP code will be trained on the full
PHMRC dataset and the model will be available for use
on the Internet following publication of this paper.
Conclusions
First developed in 2007, the Symptom Pattern Method
for verbal autopsy has been subject to in-depth
investigation and experimentation. The application of
Bayes’ theorem to verbal autopsy responses is an intui-
tive approach from a statistical standpoint; however, the
method may be difficult to fully comprehend by some
users. Consequently, it is important for the method to
be implemented on a user-friendly computational plat-
form with the option to work with different verbal
autopsy instruments. In such a setting, the Simplified
Symptom Pattern Method presented in this paper can
produce reliable, accurate results for both individual
cause of death assignment as well as cause-specific mor-
tality fraction estimates. The growing demand for more
comprehensive cause of death data in settings without
functioning health information systems could be met by
further implementation of verbal autopsy surveys and
the use of the Simplified Symptom Pattern Method to
analyze the results.
Additional material
Additional file 1: Median chance-corrected concordance (%) across
500 Dirichlet splits, by age group and cause with and without HCE.
Additional file 2: Slope, intercept, and RMSE from linear regression
of estimated versus true CSMFs, by age group and cause with and
without HCE.
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Figure 11 True versus estimated mortality fractions for stillbirths, neonate module with HCE information.
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